CLARITY PHARMACEUTICALS
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
IND approval from the US FDA for theranostic SAR-Bombesin trial in prostate cancer 2022-11-21 22:04
First patient treated in Clarity's therapeutic prostate cancer trial 2022-10-07 21:06
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US 2022-09-05 21:09
Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma 2022-08-23 21:04
Recruitment complete for Clarity's PROPELLER prostate cancer diagnostic trial 2022-07-20 21:06
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer 2022-06-06 21:08
Dr Neal Shore joins Clarity's Clinical Advisory Board 2022-05-26 21:08
Clarity's US-based Cu-64 SAR-bisPSMA trial in prostate cancer opens for recruitment 2022-03-28 21:06
New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer 2022-03-24 21:08
First patient treated in cohort 2 SARTATE™ neuroblastoma therapy trial 2022-02-25 22:04
US FDA Study May Proceed letter for Clarity's Cu-64 SAR-bisPSMA trial in prostate cancer 2022-02-07 22:08
Clarity advances to cohort 2 in the SARTATE™ neuroblastoma trial 2022-02-01 21:58
Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics 2021-12-02 21:58
Fifty percent recruitment milestone for PROPELLER prostate cancer trial 2021-12-01 21:57
Recruitment for the dosimetry phase of Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial completed 2021-11-10 22:06
Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US Clinical trials 2021-09-30 20:03
First patient treated in Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial 2021-08-25 21:18
Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial 2021-07-28 21:08
Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals 2021-05-11 21:04
Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products 2021-05-04 21:08
1 2 3